Qureight
An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.
About
Qureight is a MedTech company that provides an end-to-end AI-powered imaging platform for clinical trials, with a specific focus on lung and heart disease. They leverage 3D deep-learning imaging and AI-powered biomarkers to analyze complex medical images, identify disease progression, and accelerate drug discovery and development for biopharmaceutical companies. The platform aims to improve clinical trial design and efficiency by automating image management and providing precise clinical trial endpoints. Teams look it up for Biotechnology, Artificial Intelligence, Healthcare.
Frequently asked
What does Qureight do?
Qureight is a Biotechnology company that offers Platform. Teams look it up for Artificial Intelligence, Healthcare, Clinical Trials. It is based in Cambridge, United Kingdom and was founded in 2018. Public records show $20M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Is Qureight trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Qureight is 47 out of 100, based on site security posture and privacy practices.
How much funding has Qureight raised?
Qureight has raised a total of $20M in funding. The most recent round on record is Series B.
Where is Qureight headquartered?
Qureight is headquartered in Cambridge, United Kingdom.
When was Qureight founded?
Qureight was founded in 2018.
What industry does Qureight operate in?
Qureight operates in Biotechnology, Artificial Intelligence, Healthcare, Clinical Trials, MedTech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
Our own read on real cross-surface visibility rather than raw backlink authority. A site can carry a high Domain Rating and still be invisible where people actually look, which is what this measures.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
“CPIX | CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH.”
View on Reddit“Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF.”
View on Reddit“Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.”
View on Reddit“Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.